Michael R. Mattern
0000-0002-8595-000X
Publication & Citation Trends
Most Cited Works
Publications
127 total
TAM receptors attenuate murine NK‐cell responses via E3 ubiquitin ligase Cbl‐b OA
Cited by 33
Semantic Scholar
Using Ubiquitin Binders to Decipher the Ubiquitin Code. OA
Cited by 67
Semantic Scholar
Abstract A206: Small-molecule Cbl-b inhibitors as novel intracellular checkpoint inhibitors for cancer immunotherapy
Cited by 3
Semantic Scholar
Abstract B202: Covalent irreversible usp7 inhibitors for cancer immunotherapy
Cited by 1
Semantic Scholar
Abstract B193: Characterization of selective active-site targeted covalent inhibitors of usp7
Cited by 0
Semantic Scholar
Active site-targeted covalent irreversible inhibitors of USP7 impair the functions of Foxp3+ T-regulatory cells by promoting ubiquitination of Tip60 OA
Cited by 49
Semantic Scholar
Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology Therapies.
Cited by 40
Semantic Scholar
Abstract 5336: Characterization of selective covalent inhibitors of USP7
Cited by 0
Semantic Scholar
Research Topics
Ubiquitin and proteasome pathways
(37)
Cancer therapeutics and mechanisms
(34)
DNA Repair Mechanisms
(29)
DNA and Nucleic Acid Chemistry
(15)
Peptidase Inhibition and Analysis
(15)
Frequent Co-Authors
Affiliations
Carl von Ossietzky Universität Oldenburg
National Institutes of Health
Trier University of Applied Sciences
Scripps Institution of Oceanography
University of California, San Francisco